middle.news
How Did Dimerix Surpass Recruitment Targets in Its Critical FSGS Trial?
9:32am on Tuesday 10th of March, 2026 AEDT
•
Healthcare
Read Story
How Did Dimerix Surpass Recruitment Targets in Its Critical FSGS Trial?
9:32am on Tuesday 10th of March, 2026 AEDT
Key Points
333 adult patients dosed, surpassing target of 286
Pediatric cohort recruitment ongoing as separate group
Trial spans 21 countries with multi-centre, placebo-controlled design
Positive interim analysis showed DMX-200 reduced proteinuria
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
DIMERIX (ASX:DXB)
OPEN ARTICLE